Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study

Polypharmacy increases the risk of drug–drug interactions that may disturb treatment effects. The aim of this study was to investigate the frequency of codispensing of potentially interacting or contraindicated drugs related to PH‐specific treatment in the Swedish pulmonary arterial hypertension (PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Norell, Puck N., Ivarsson, Bodil, Selin, Maria, Kjellström, Barbro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306325/
https://www.ncbi.nlm.nih.gov/pubmed/36203946
http://dx.doi.org/10.1002/pul2.12114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306325/
https://www.ncbi.nlm.nih.gov/pubmed/36203946
http://dx.doi.org/10.1002/pul2.12114

Ejemplares similares